2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
10
Lung Neoplasms
8
Colorectal Neoplasms
6
Hematologic Neoplasms
5
Prostatic Neoplasms
4
Hodgkin Disease
4
Carcinoma, Non-Small-Cell Lung
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Motor Activity
3
Pancreatic Neoplasms
2
Obesity
2
Neoplasms
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Hematopoietic and Lymphoid System Neoplasm
2
Gastrointestinal Diseases
2
Cardiotoxicity
2
Urinary Bladder Neoplasms
1
Trastuzumab Cardiotoxicity
1
Stress Disorders, Post-Traumatic
1
Small Cell Lung Carcinoma
1
Sleep Wake Disorders
1
Sedentary Behavior
1
Sarcopenia
1
Radiation Pneumonitis
1
Radiation Fibrosis Syndrome
1
Polycystic Ovary Syndrome
1
Pelvic Neoplasms
1
Pathologically Proven Gastrointestinal Malignancy
1
Oropharyngeal Neoplasms
1
Interventions
Metformin
152
Clomiphene
51
Letrozole
40
Inositol
34
Folic Acid
18
Progesterone
17
Exercise
17
Ethinyl Estradiol
13
Estradiol
13
Chorionic Gonadotropin
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Contraceptives, Oral
12
cetrorelix
11
Pioglitazone
10
High-Intensity Interval Training
10
Cholecalciferol
10
Triptorelin Pamoate
9
Tablets
9
Spironolactone
9
Menotropins
8
Diet
8
Vitamin D
7
Thioctic Acid
7
Surveys and Questionnaires
7
Liraglutide
7
Gonadotropins
7
Acupuncture Therapy
7
follitropin alfa
6
drospirenone
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycystic Ovary Syndrome
×
Exercise Test
×
Clear all
NCT05215223
2023-10-17
WBV
Cairo University
Phase NA
Completed
46 enrolled